Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 942-438-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study performed under GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- inspected March 2014; signature: May 2014
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Reaction mass of (1RS,3RS)-3-methyl-3-(4-methylpentyl)cyclohexyl acetate and (2RS,4aRS,8aSR)-5,5,8a-trimethyldecahydro-2-naphthalenyl acetate and (2RS,4aRS,8aRS)-5,5,8a-trimethyldecahydro-2-naphthalenyl acetate
- Molecular formula:
- not applicable (reaction mass of constitutional isomers)
- IUPAC Name:
- Reaction mass of (1RS,3RS)-3-methyl-3-(4-methylpentyl)cyclohexyl acetate and (2RS,4aRS,8aSR)-5,5,8a-trimethyldecahydro-2-naphthalenyl acetate and (2RS,4aRS,8aRS)-5,5,8a-trimethyldecahydro-2-naphthalenyl acetate
- Details on test material:
- - Physical state: Liquid.
- Storage condition of test material: Room temperature in the dark
- Other: Colourless
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9
- Test concentrations with justification for top dose:
- Experiment 1 (plate incorporation method): 0, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate
Experiment 2 (pre-incubation method):
Salmonella strains with and without S9-mix - TA98, TA100, TA1535: 0, 1.5, 5, 15, 50, 150, 500, 1500, 5000 µg/plate
Salmonella strains with S9 mix - TA1537: 0, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 µg/plate
Salmonella strain without S9-mix - TA1537: 0, 1.5, 5, 15, 50, 150, 500, 1500, 5000 µg/plate
E.coli strain with and without S9-mix - WP2uvrA: 0, 5, 15, 50, 150, 500, 1500, 5000 µg/plate
Up to eight test item dose levels were selected in Experiment 2 in order to achieve both a minimum of four non-toxic doses and the toxic limit of the test item following the change in test methodology. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: dimethyl sulphoxide (DMSO)
- Justification for choice of solvent/vehicle: The test item was immiscible in sterile distilled water at 50 mg/mL but was fully miscible in dimethyl sulphoxide at the same concentration and acetone at 100 mg/mL in solubility checks performed. Dimethyl sulphoxide was selected as the vehicle.
- Other: Formulated concentrations were adjusted by an appropriate factor to allow for the stated purity of the test substance.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 2-Aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: Experiment 1. in medium; in agar (plate incorporation) ; Experiment 2. in medium; in agar (pre-incubation)
DURATION
- Exposure duration:
Experiment 1. All of the plates were incubated at 37 ± 3 ºC for approximately 48 hours and scored for the presence of revertant colonies using an automated colony counting system. The plates were viewed microscopically for evidence of thinning (toxicity). Several manual counts were required, predominantly due to interference in the base agar e.g. minor precipitation of salts/dust particles and marks on the base of the plates slightly distorting the counts.
Experiment 2. 0.1 mL of the appropriate bacterial strain culture, 0.5 mL of phosphate buffer OR S9-mix (as appropriate) and 0.1 mL of the test item formulation, vehicle or 0.1 mL of appropriate positive control were incubated at 37 ± 3 ºC for 20 minutes (with shaking) prior to addition of 2 mL of molten amino-acid supplemented media Subsequently, the procedure for incubation and duration was the same as in Experiment 1.
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby, 1979).
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out of historical range response (Cariello and Piegorsch, 1996)).
A test item is considered non-mutagenic (negative) in the test system if the above criteria are not met.
In instances of data prohibiting definitive judgement about test item activity are reported as equivocal. - Statistics:
- Statistical methods (Mahon, et al.); as recommended by the UKEMS Subcommittee on Guidelines for Mutagenicity Testing, Report - Part III (1989).
Results and discussion
Test resultsopen allclose all
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1 : Test Results: Experiment 1 with and without metabolic activation and results of concurrent positive controls
S9-Mix (-) |
Dose Level Per Plate |
Number of revertants (mean) +/- SD |
|||||||||
Base-pair substitution strains |
Frameshift strains |
||||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
|||||||
Solvent Control (DMSO) |
68 74 65 |
(69) 4.6# |
9 7 15 |
(10) 4.2 |
21 33 20 |
(25) 7.2 |
20 12 19 |
(17) 4.4 |
9 7 8 |
(8) 1.0 |
|
1.5 µg |
67 69 63 |
(66) 3.1 |
19 9 9 |
(12) 5.8 |
24 29 33 |
(29) 4.5 |
24 16 15 |
(18) 4.9 |
8 11 15 |
(11) 3.5 |
|
5 µg |
67 83 86 |
(79) 10.2 |
23 8 8 |
(13) 8.7 |
27 28 27 |
(27) 0.6 |
24 16 13 |
(18) 5.7 |
20 9 12 |
(14) 5.7 |
|
15 µg |
74 67 75 |
(72) 4.4 |
12 8 11 |
(10) 2.1 |
29 28 32 |
(30) 2.1 |
23 15 23 |
(20) 4.6 |
8 11 5 |
(8) 3.0 |
|
50 µg |
64 84 80 |
(76) 10.6 |
13 15 11 |
(13) 2.0 |
16 32 21 |
(23) 8.2 |
8 11 12 |
(10) 2.1 |
3 13 4 |
(7) 5.5 |
|
150 µg |
64 61 67 |
(64) 3.0 |
11 16 8 |
(12) 4.0 |
15 32 23 |
(23) 8.5 |
9 25 12 |
(15) 8.5 |
7 8 13 |
(9) 3.2 |
|
500 µg |
64 64 55 |
(61) 5.2 |
17 16 11 |
(15) 3.2 |
23 35 35 |
(31) 6.9 |
11 19 16 |
(15) 4.0 |
8 13 3 |
(8) 5.0 |
|
1500 µg |
64 P 59 P 75 P |
(66) 8.2 |
16 P 16 P 9 P |
(14) 4.0 |
27 P 32 P 27 P |
(29) 2.9 |
13 P 13 P 17 P |
(14) 2.3 |
9 P 8 P 5 P |
(7) 2.1 |
|
5000 µg |
53 PS 45 PS 60 PS |
(53) 7.5 |
15 PS 11 PS 12 PS |
(13) 2.1 |
35 P 28 P 27 P |
(30) 4.4 |
17 P 15 P 15 P |
(16) 1.2 |
1 PS 5 PS 8 PS |
(5) 3.5 |
|
Positive controls S9-Mix (-) |
Name Dose Level No. of Revertants |
ENNG |
ENNG |
ENNG |
4NQO |
9AA |
|||||
3 µg |
5 µg |
2 µg |
0.2 µg |
80 µg |
|||||||
370 564 493 |
(476) 98.2 |
305 521 380 |
(402) 109.7 |
976 923 925 |
(941) 30.0 |
136 142 162 |
(147) 13.6 |
727 921 1066 |
(905) 170.1 |
||
|
|||||||||||
S9-Mix (+) |
Dose Level Per Plate |
Number of revertants (mean) +/- SD |
|||||||||
Base-pair substitution strains |
Frameshift strains |
||||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
|||||||
Solvent Control (DMSO) |
72 84 80 |
(79) 6.1# |
11 9 10 |
(10) 1.0 |
36 29 29 |
(31) 4.0 |
29 17 25 |
(24) 6.1 |
8 19 8 |
(12) 6.4 |
|
1.5 µg |
71 72 72 |
(72) 0.6 |
15 17 13 |
(15) 2.0 |
43 31 39 |
(38) 6.1 |
11 31 23 |
(22) 10.1 |
20 20 7 |
(16) 7.5 |
|
5 µg |
83 68 83 |
(78) 8.7 |
15 13 13 |
(14) 1.2 |
27 32 43 |
(34) 8.2 |
29 28 24 |
(27) 2.6 |
8 12 13 |
(11) 2.6 |
|
15 µg |
61 65 68 |
(65) 3.5 |
9 15 15 |
(13) 3.5 |
19 25 44 |
(29) 13.1 |
8 32 27 |
(22) 12.7 |
12 7 15 |
(11) 4.0 |
|
50 µg |
74 71 73 |
(73) 1.5 |
8 9 16 |
(11) 4.4 |
23 21 31 |
(25) 5.3 |
16 23 19 |
(19) 3.5 |
12 8 15 |
(12) 3.5 |
|
150 µg |
66 64 64 |
(65) 1.2 |
9 10 9 |
(9) 0.6 |
25 37 33 |
(32) 6.1 |
27 16 27 |
(23) 6.4 |
7 4 7 |
(6) 1.7 |
|
500 µg |
72 78 76 |
(75) 3.1 |
9 5 7 |
(7) 2.0 |
47 40 31 |
(39) 8.0 |
16 15 17 |
(16) 1.0 |
5 8 3 |
(5) 2.5 |
|
1500 µg |
35 P 34 P 37 P |
(35) 1.5 |
3 P 2 P 6 P |
(4) 2.1 |
28 P 31 P 32 P |
(30) 2.1 |
9 P 12 P 24 P |
(15) 7.9 |
1 PS 0 PS 0 PS |
(0) 0.6 |
|
5000 µg |
29 PS 19 PS 24 PS |
(24) 5.0 |
3 PS 2 PS 2 PS |
(2) 0.6 |
25 P 35 P 19 P |
(26) 8.1 |
8 P 8 P 7 P |
(8) 0.6 |
0 PV 0 PV 0 PV |
(0) 0.0 |
|
Positive controls S9-Mix (+) |
Name Dose Level No. of Revertants |
2AA |
2AA |
2AA |
BP |
2AA |
|||||
1 µg |
2 µg |
10 µg |
5 µg |
2 µg |
|||||||
1430 1625 1514 |
(1523) 97.8 |
266 286 299 |
(284) 16.6 |
246 226 311 |
(261) 44.4 |
179 212 243 |
(211) 32.0 |
699 756 334 |
(596) 229.0 |
Table 2 : Test Results: Experiment 2 with and without metabolic activation and results of concurrent positive controls
S9-Mix (-) |
Dose Level Per Plate |
Number of revertants (mean) +/- SD |
|||||||||
Base-pair substitution strains |
Frameshift strains |
||||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
|||||||
Solvent Control (DMSO) |
78 64 76 |
(73) 7.6# |
9 13 8 |
(10) 2.6 |
20 23 25 |
(23) 2.5 |
17 23 20 |
(20) 3.0 |
11 4 9 |
(8) 3.6 |
|
1.5 µg |
76 82 68 |
(75) 7.0 |
9 15 12 |
(12) 3.0 |
N/T |
13 15 23 |
(17) 5.3 |
7 11 8 |
(9) 2.1 |
||
5 µg |
65 71 71 |
(69) 3.5 |
9 12 9 |
(10) 1.7 |
15 17 17 |
(16) 1.2 |
24 27 23 |
(25) 2.1 |
8 4 8 |
(7) 2.3 |
|
15 µg |
79 82 71 |
(77) 5.7 |
9 11 9 |
(10) 1.2 |
25 21 20 |
(22) 2.6 |
12 15 13 |
(13) 1.5 |
4 5 11 |
(7) 3.8 |
|
50 µg |
69 63 64 |
(65) 3.2 |
17 9 9 |
(12) 4.6 |
21 11 19 |
(17) 5.3 |
11 17 19 |
(16) 4.2 |
12 8 11 |
(10) 2.1 |
|
150 µg |
71 71 61 |
(68) 5.8 |
7 9 8 |
(8) 1.0 |
27 19 20 |
(22) 4.4 |
19 15 15 |
(16) 2.3 |
11 11 12 |
(11) 0.6 |
|
500 µg |
67 74 74 |
(72) 4.0 |
8 15 8 |
(10) 4.0 |
23 23 9 |
(18) 8.1 |
16 16 24 |
(19) 4.6 |
5 12 4 |
(7) 4.4 |
|
1500 µg |
75 P 72 P 74 P |
(74) 1.5 |
4 PS 4 PS 10 PS |
(6) 3.5 |
21 P 8 P 28 P |
(19) 10.1 |
20 P 15 P 17 P |
(17) 2.5 |
5 P 5 P 5 P |
(5) 0.0 |
|
5000 µg |
64 PS 64 PS 57 PS |
(62) 4.0 |
5 PS 7 PS 11 PS |
(8) 3.1 |
19 P 24 P 20 P |
(21) 2.6 |
15 P 15 P 9 P |
(13) 3.5 |
4 PS 7 PS 4 PS |
(5) 1.7 |
|
Positive controls S9-Mix (-) |
Name Dose Level No. of Revertants |
ENNG |
ENNG |
ENNG |
4NQO |
9AA |
|||||
3 µg |
5 µg |
2 µg |
0.2 µg |
80 µg |
|||||||
374 433 425 |
(411) 32.0 |
345 489 294 |
(376) 101.1 |
555 537 600 |
(564) 32.4 |
132 162 167 |
(154) 18.9 |
992 1155 588 |
(912) 291.9 |
||
|
|||||||||||
S9-Mix (+) |
Dose Level Per Plate |
Number of revertants (mean) +/- SD |
|||||||||
Base-pair substitution strains |
Frameshift strains |
||||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
|||||||
Solvent Control (DMSO) |
84 72 75 |
(77) 6.2# |
8 8 9 |
(8) 0.6 |
25 32 25 |
(27) 4.0 |
17 20 17 |
(18) 1.7 |
9 12 9 |
(10) 1.7 |
|
0.5 µg |
N/T |
N/T |
N/T |
N/T |
11 4 8 |
(8) 3.5 |
|||||
1.5 µg |
94 67 86 |
(82) 13.9 |
9 11 11 |
(10) 1.2 |
N/T |
15 28 16 |
(20) 7.2 |
8 11 7 |
(9) 2.1 |
||
5 µg |
90 76 78 |
(81) 7.6 |
11 8 7 |
(9) 2.1 |
21 28 24 |
(24) 3.5 |
17 21 31 |
(23) 7.2 |
9 7 8 |
(8) 1.0 |
|
15 µg |
64 83 80 |
(76) 10.2 |
7 13 8 |
(9) 3.2 |
20 16 29 |
(22) 6.7 |
19 23 17 |
(20) 3.1 |
7 8 7 |
(7) 0.6 |
|
50 µg |
82 86 75 |
(81) 5.6 |
8 8 11 |
(9) 1.7 |
15 29 24 |
(23) 7.1 |
20 25 25 |
(23) 2.9 |
13 11 7 |
(10) 3.1 |
|
150 µg |
71 82 78 |
(77) 5.6 |
11 8 12 |
(10) 2.1 |
24 27 24 |
(25) 1.7 |
17 20 21 |
(19) 2.1 |
11 8 11 |
(10) 1.7 |
|
500 µg |
56 S 45 S 55 S |
(52) 6.1 |
4 S 11 S 8 S |
(8) 3.5 |
31 28 23 |
(27) 4.0 |
21 11 9 |
(14) 6.4 |
9 S 5 S 8 S |
(7) 2.1 |
|
1500 µg |
49 PS 48 PS 47 PS |
(48) 1.0 |
5 PS 5 PS 7 PS |
(6) 1.2 |
32 P 33 P 24 P |
(30) 4.9 |
15 P 20 P 15 P |
(17) 2.9 |
9 PS 9 PS 5 PS |
(8) 2.3 |
|
5000 µg |
56 PS 23 PS 20 PS |
(33) 20.0 |
5 PS 5 PS 7 PS |
(6) 1.2 |
29 P 19 P 15 P |
(21) 7.2 |
21 P 16 P 21 P |
(19) 2.9 |
N/T |
||
Positive controls S9-Mix (+) |
Name Dose Level No. of Revertants |
2AA |
2AA |
2AA |
BP |
2AA |
|||||
1 µg |
2 µg |
10 µg |
5 µg |
2 µg |
|||||||
1012 1005 834 |
(950) 100.8 |
207 186 195 |
(196) 10.5 |
103 130 118 |
(117) 13.5 |
102 134 118 |
(118) 16.0 |
241 242 242 |
(242) 0.6 |
ENNG N-ethyl-N'-nitro-N-nitrosoguanidine
4NQO 4-Nitroquinoline-1-oxide
9AA 9-Aminoacridine
BP Benzo(a)pyrene
2AA 2-Aminoanthracene
P Test item precipitate
S Sparse bacterial background lawn
V Very weak bacterial background lawn
# Standard deviation
N/T Not tested at this dose level
Table 3. Spontaneous Mutation Rates (Concurrent Negative Controls)
Experiment 1 |
||||||||||
Number of revertants (mean number of colonies per plate) |
||||||||||
Base-pair substitution type |
Frameshift type |
|||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||||||
98 |
|
7 |
|
27 |
|
9 |
|
11 |
|
|
98 |
(88) |
12 |
(10) |
32 |
(33) |
17 |
(15) |
11 |
(10) |
|
69 |
|
11 |
|
39 |
|
20 |
|
8 |
|
|
Experiment 2 |
||||||||||
Number of revertants (mean number of colonies per plate) |
||||||||||
Base-pair substitution type |
Frameshift type |
|||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||||||
103 |
|
8 |
|
21 |
|
21 |
|
9 |
|
|
96 |
(107) |
8 |
(8) |
19 |
(21) |
31 |
(26) |
7 |
(8) |
|
123 |
|
9 |
|
24 |
|
25 |
|
8 |
|
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Under the conditions of this study the test material was considered to be non-mutagenic in the presence and absence of S9 activation. - Executive summary:
The study was performed to the requirements of OECD Guideline 471, EU Method B13/14, US EPA OCSPP 870.5100 and Japanese guidelines for bacterial mutagenicity testing under GLP, to evaluate the potential mutagenicity of the test substance in a bacterial reverse mutation assay using S.typhimurium strains TA98, TA100, TA1535, TA1537 and E.coli strain WP2uvrA- in both the presence and absence of S-9 mix. The test strains were treated with the test substance using both the Ames plate incorporation and pre incubation methods at up to eight dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolizing system (10% liver S9 in standard co-factors). The dose range for Experiment 1 was predetermined and was 1.5 to 5000 µg/plate. The experiment was repeated on a separate day (pre-incubation method) using fresh cultures of the bacterial strains and fresh test item formulations. The dose range was amended following the results of Experiment 1 and ranged between 0.5 and 5000 µg/plate depending on bacterial tester strain and absence or presence of S9-mix. Up to eight test item dose levels were selected in Experiment 2 in order to achieve both a minimum of four non-toxic doses and the toxic limit of the test item following the change in test methodology. The vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated. The maximum dose level of the test recommended in the first experiment was selected as the maximum recommended dose level of 5000 µg/plate. Following Experiment 1 and observed cytotoxicity in associated strains a subsequent Experiment 2 was conducted with the pre-incubation method wherein the same maximum dose level or the toxic limit was used in the second mutation test, depending on bacterial tester strain and absence or presence of S9-mix. A similar response in terms of test item toxicity to the bacterial tester strains was noted in the second mutation test (employing the pre-incubation modification) with weakened lawns noted in the presence of S9-mix to TA100, TA1535 and TA1537 at and above 500 µg/plate. In the absence of S9-mix weakened lawns were initially noted from 1500 µg/plate to TA1535 and at 5000 µg/plate to TA100 and TA1537. Once again, there was no visible reduction in the growth of the bacterial background lawns of TA98 and WP2uvrA at any test substance dose level, either in the presence or absence of S9-mix. Therefore these strains were tested at up to 5000 µg/plate. A test item precipitate (greasy in appearance) was noted at and above 1500 µg/plate, this observation did not prevent the scoring of revertant colonies. It was concluded that, under the conditions of this assay, the test substance gave a negative, i.e. non-mutagenic response in S.typhimurium strains TA98, TA100, TA1535, TA1537 and E.coli strain WP2uvrA- in the presence and absence of S-9 mix.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.